4//SEC Filing
Schwartz Jonathan David 4
Accession 0001140361-23-008104
CIK 0001281895other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:28 PM ET
Size
5.1 KB
Accession
0001140361-23-008104
Insider Transaction Report
Form 4
Schwartz Jonathan David
See Remarks
Transactions
- Sale
Common Stock
2023-02-17$19.06/sh−3,557$67,796→ 94,546 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.
- [F2]This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001726398
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:28 PM ET
- Size
- 5.1 KB